PROGRESSIVE DISEASE
Clinical trials for PROGRESSIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE DISEASE trials appear
Sign up with your email to follow new studies for PROGRESSIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple therapy offers new hope for Hard-to-Treat colorectal cancer
Disease control OngoingThis study tests a combination of two targeted drugs (encorafenib and cetuximab) plus an immunotherapy drug (nivolumab) in people with advanced colorectal cancer that has a specific BRAF mutation and is stable (not MSI-high). The goal is to see if this triple therapy can shrink t…
Matched conditions: PROGRESSIVE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
New drug combo shows promise for recurrent ovarian and endometrial cancers
Disease control OngoingThis early-phase study tests a combination of two oral and intravenous drugs (niraparib and copanlisib) in about 31 people whose endometrial, ovarian, or related cancers have returned. The main goal is to find the safest dose and understand side effects. Participants must have ce…
Matched conditions: PROGRESSIVE DISEASE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 06:46 UTC